Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
1986
|
| gptkbp:ATCCode |
A02BA03
|
| gptkbp:brand |
gptkb:famotidine
|
| gptkbp:chemicalFormula |
C8H15N7O2S3
|
| gptkbp:contraindication |
allergy to famotidine
|
| gptkbp:drugClass |
gptkb:H2_blocker
|
| gptkbp:eliminationHalfLife |
2.5-3.5 hours
|
| gptkbp:excretion |
renal
|
| gptkbp:FDAApproved |
yes
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pepcid
|
| gptkbp:legalStatus |
OTC in US
Rx in some countries |
| gptkbp:manufacturer |
gptkb:Johnson_&_Johnson
|
| gptkbp:metabolism |
minimal hepatic
|
| gptkbp:OTC |
yes
|
| gptkbp:pregnancyCategory |
B
|
| gptkbp:prescriptionStatus |
OTC and prescription
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
diarrhea
constipation dizziness headache |
| gptkbp:usedFor |
gptkb:gastroesophageal_reflux_disease
heartburn stomach ulcers |
| gptkbp:bfsParent |
gptkb:Merck_&_Co.
|
| gptkbp:bfsLayer |
4
|